CG
BIOR

Cutler Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Cutler Group’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$1K – 4454
2023
Q1 		$1K Buy
100
+82
+456% +$2.78K ﹤0.01% 3662
2022
Q4 		$15K Sell
18
-10
-36% -$729 ﹤0.01% 2451
2022
Q3 		$27K Sell
28
-18
-39% -$3.24K ﹤0.01% 2388
2022
Q2 		$38K Sell
46
-14
-23% -$2.95K ﹤0.01% 2166
2022
Q1 		$46K Sell
60
-353
-85% -$134K ﹤0.01% 2325
2021
Q4 		$94K Buy
+413
New +$296K ﹤0.01% 1907

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Cutler Group's BIOR Position: Q2 2023 in Review

Cutler Group sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2023, closing a stake of 2 shares — an estimated $71 sold.

Cutler Group first reported a position in BIOR in Q4 2021 and held it in 6 quarters. The position peaked at $102K in Q4 2021. 30 funds tracked by Wall St. Rank hold BIOR as of Q2 2023.

  • Cutler Group reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 2 Biora Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $71.
  • Cutler Group first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Cutler Group's Biora Therapeutics, Inc. Common Stock position peaked at $102K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.